First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy

BACKGROUND: Helicobacter pylori (H. pylori) treatment remains a challenge for physicians. Although highly effective, the standard sequential therapy fails in a certain number of patients. Moreover, the cure rate following a levofloxacin-amoxicillin second-line triple therapy seems to be decreasing....

Descripción completa

Detalles Bibliográficos
Autores principales: Zullo, Angelo, Ridola, Lorenzo, Efrati, Cesare, Giorgio, Floriana, Nicolini, Giorgia, Cannaviello, Claudio, Alvaro, Domenico, Hassan, Cesare, Gatta, Luigi, Francesco, Vincenzo De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188933/
https://www.ncbi.nlm.nih.gov/pubmed/25330819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188933/
https://www.ncbi.nlm.nih.gov/pubmed/25330819

Ejemplares similares